ArticleMemorias do Instituto Oswaldo Cruz2020

Evaluation of different total Leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a Toll-like receptor-3 agonist to prevent cutaneous leishmaniasis.

María José Germanó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.